Can Omics Improve Parasite Surveillance? - Scorecard - MDSpire

Can Omics Improve Parasite Surveillance?

  • By

  • Jessica Allerton

  • June 11, 2026

  • 4 min

Share

Clinical Scorecard: Can Omics Improve Parasite Surveillance?

At a Glance

CategoryDetail
ConditionParasitic infections
Key MechanismsMetagenomics and proteomics for improved detection and characterization of parasites
Target PopulationIndividuals at risk of parasitic infections
Care SettingClinical laboratories

Key Highlights

  • Metagenomics enables simultaneous detection of multiple microorganisms, including low-abundance parasites.
  • Current testing methods may miss unexpected pathogens due to reliance on microscopy and targeted PCR.
  • Standardized workflows and high-quality reference genomes are critical for reliable metagenomic results.
  • Metagenomics supports longitudinal monitoring of parasitic infections.
  • Population-scale surveillance can reveal geographic differences in parasite prevalence.

Guideline-Based Recommendations

Diagnosis

  • Use species-specific computational pipelines for detecting eukaryotic parasites.

Management

  • Implement metagenomics alongside traditional methods for comprehensive parasite detection.

Monitoring & Follow-up

  • Utilize metagenomics for longitudinal monitoring of parasitic infections.

Risks

  • Challenges include contamination, sensitivity issues, and distinguishing clinically relevant findings from background noise.

Patient & Prescribing Data

Individuals undergoing testing for parasitic infections

Metagenomics may inform treatment decisions through improved detection of parasites.

Clinical Best Practices

  • Establish standardized workflows for sample collection, DNA extraction, and computational analysis.
  • Validate thresholds for identifying parasite subtypes to reduce false positives and negatives.
  • Incorporate proteomics to complement metagenomic findings.

Related Resources & Content

Original Source(s)

Related Content